Brian Balchin's questions to Indivior PLC (INDV) leadership • Q4 2024
Question
Brian Balchin of Jefferies, on behalf of James Vane-Tempest, questioned the profitability of OPVEE given its $10-15 million revenue guidance and associated costs. He also asked why R&D expenses, guided at $85-90 million, are not lower following the discontinuation of certain programs.
Answer
CFO Ryan Preblick stated that OPVEE costs are aligned with its strategic programs and have been relatively flat, with the business expected to be accretive next year. CEO Mark Crossley added that the OPVEE team is very small and focused. Regarding R&D, Preblick explained the current spending primarily reflects the progression of two Phase II OUD assets and ongoing real-world evidence generation for SUBLOCADE.